Michiyo Iba

ORCID: 0000-0001-7181-7745
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Alzheimer's disease research and treatments
  • Parkinson's Disease Mechanisms and Treatments
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Neuroscience and Neuropharmacology Research
  • Visual perception and processing mechanisms
  • Neurological disorders and treatments
  • Neural and Behavioral Psychology Studies
  • Neural dynamics and brain function
  • Nuclear Receptors and Signaling
  • Memory and Neural Mechanisms
  • Computational Drug Discovery Methods
  • Botulinum Toxin and Related Neurological Disorders
  • Cholinesterase and Neurodegenerative Diseases
  • Cancer Treatment and Pharmacology
  • Insect and Arachnid Ecology and Behavior
  • Neurobiology and Insect Physiology Research
  • Prion Diseases and Protein Misfolding
  • RNA Interference and Gene Delivery
  • Neurological Disease Mechanisms and Treatments
  • Neurological diseases and metabolism
  • Motor Control and Adaptation
  • Single-cell and spatial transcriptomics
  • Stress Responses and Cortisol
  • Phytochemical Studies and Bioactivities
  • Calpain Protease Function and Regulation

National Institute on Aging
2018-2025

National Institutes of Health
2018-2024

Institute on Aging
2010-2021

University of Pennsylvania
2007-2017

Institute for Neurodegenerative Disorders
2011-2017

Tamagawa University
2008-2011

Hospital of the University of Pennsylvania
2011

Philadelphia University
2007

Japan Science and Technology Agency
2001-2003

Hokkaido University
1995-2003

Tauopathies, including Alzheimer's disease (AD) and frontotemporal lobar degeneration with tau pathologies, are neurodegenerative diseases characterized by neurofibrillary tangles (NFTs) comprising filamentous protein. Although emerging evidence suggests that pathology may be transmitted, we demonstrate here synthetic fibrils sufficient to transmit inclusions in a mouse model. Specifically, intracerebral inoculation of young PS19 mice overexpressing mutant human (P301S) preformed (pffs)...

10.1523/jneurosci.2642-12.2013 article EN cc-by-nc-sa Journal of Neuroscience 2013-01-16

Filamentous tau aggregates are hallmark lesions in numerous neurodegenerative diseases, including Alzheimer’s disease (AD). Cell culture and animal studies showed that fibrils can undergo cell-to-cell transmission seed aggregation of soluble tau, but this phenomenon was only robustly demonstrated models overexpressing tau. In study, we found intracerebral inoculation purified from AD brains (AD-tau), not synthetic fibrils, resulted the formation abundant inclusions anatomically connected...

10.1084/jem.20160833 article EN The Journal of Experimental Medicine 2016-10-17

Neurodegenerative tauopathies, such as Alzheimer's disease (AD), are characterized by insoluble deposits of hyperphosphorylated tau protein within brain neurons. Increased phosphorylation and decreased solubility has been proposed to diminish normal stabilization microtubules (MTs), thereby leading neuronal dysfunction. Earlier studies have provided evidence that small molecule MT-stabilizing drugs used in the treatment cancer may utility tauopathies. However, it not established whether with...

10.1523/jneurosci.4922-11.2012 article EN cc-by-nc-sa Journal of Neuroscience 2012-03-14

Neurons in the brains of those with Alzheimer's disease (AD) and many frontotemporal dementias (FTDs) contain neurofibrillary tangles comprised hyperphosphorylated tau protein. Tau normally stabilizes microtubules (MTs), misfolding could lead to a loss this function consequent MT destabilization neuronal dysfunction. Accordingly, possible therapeutic strategy for AD related "tauopathies" is treatment MT-stabilizing anti-cancer drug such as paclitaxel. However, paclitaxel taxanes have poor...

10.1523/jneurosci.3059-10.2010 article EN cc-by-nc-sa Journal of Neuroscience 2010-10-13

Because overactivation of the hypothalamic–pituitary–adrenal (HPA) axis occurs in Alzheimer's disease (AD), dysregulation stress neuromediators may play a mechanistic role pathophysiology AD. However, effects on tau phosphorylation are poorly understood, and relationship between corticosterone corticotropin-releasing factor (CRF) both β-amyloid (Aβ) pathology remain unclear. Therefore, we first established model chronic stress, which exacerbates Aβ accumulation Tg2576 mice then extended this...

10.1523/jneurosci.3836-11.2011 article EN cc-by-nc-sa Journal of Neuroscience 2011-10-05

Tauopathies are neurodegenerative disorders characterized by the accumulation of abnormal tau protein leading to cognitive and/or motor dysfunction. To understand relationship between pathology and behavioral impairments, we comprehensively assessed abnormalities in a mouse tauopathy model expressing human P301S mutant early stage disease detect its initial neurological manifestations. Behavioral abnormalities, shown open field test, elevated plus-maze hot plate Y-maze Barnes maze Morris...

10.1371/journal.pone.0021050 article EN cc-by PLoS ONE 2011-06-15

Synucleinopathies of the aging population are an heterogeneous group neurological disorders that includes Parkinson's disease (PD) and dementia with Lewy bodies (DLB) characterized by progressive accumulation α-synuclein in neuronal glial cells. Toll-like receptor 2 (TLR2), a pattern recognition immune receptor, has been implicated pathogenesis synucleinopathies because TLR2 is elevated brains patients PD mediator neurotoxic pro-inflammatory effects extracellular aggregates. Therefore,...

10.1186/s13024-018-0276-2 article EN cc-by Molecular Neurodegeneration 2018-08-09

Abstract Background α-Synuclein (α-syn) is a pre-synaptic protein which progressively accumulates in neuronal and non-neuronal cells neurodegenerative diseases such as Parkinson’s disease (PD), dementia with Lewy bodies (DLB), multiple system atrophy. Recent evidence suggests that aberrant immune activation may be involved neurodegeneration PD/DLB. While previous studies have often focused on the microglial responses, less known about role of peripheral these disorders. Methods To understand...

10.1186/s12974-020-01888-0 article EN cc-by Journal of Neuroinflammation 2020-07-17
Ruth Chia Anindita Ray Zalak Shah Jinhui Ding Paola Ruffo and 95 more Masashi Fujita Vilas Menon Sara Sáez-Atiénzar Paolo Reho Karri Kaivola Ronald L. Walton Regina H. Reynolds Ramita Karra S.S.J. Sait Fulya Akçimen Mónica Díez-Fairén Ignacio Álvarez Alessandra Fanciulli Nadia Stefanova Klaus Seppi Susanne Duerr Fabian Leys Florian Krismer Victoria Sidoroff Alexander Zimprich Walter Pirker Olivier Rascol Alexandra Foubert‐Samier Wassilios G. Meissner François Tison Anne Pavy‐Le Traon Maria Teresa Pellecchia Paolo Barone Maria Claudia Russillo Juan Marín‐Lahoz Jaime Kulisevsky Soraya Torres Pablo Mir María Teresa Periñán Christos Proukakis Viorica Chelban Lesley Wu Yee Yen Goh Laura Parkkinen Joshua Shulman Christopher Kobylecki Jennifer A. Saxon Sara Rollinson Emily M. Garland Italo Biaggioni Irene Litvan Ileana Gabriela Sanchez Rubio Roy N. Alcalay Kimberly Kwei Steven Lubbe Qinwen Mao Margaret E. Flanagan Rudolph J. Castellani Vikram Khurana Alain Ndayisaba Andrea Calvo Gabriele Mora Antonio Canosa Gianluca Floris Ryan C. Bohannan Anni Moore Lucy Norcliffe‐Kaufmann Jose‐Alberto Palma Horacio Kaufmann Changyoun Kim Michiyo Iba Eliezer Masliah Ted M. Dawson Liana S. Rosenthal Alexander Pantelyat Marilyn S. Albert Olga Pletniková Juan C. Troncoso Jon Infante Carmen Lage Pascual Sánchez‐Juan Geidy E. Serrano Thomas G. Beach Pau Pástor Huw R. Morris Diego Albani Jordi Clarimón Gregor K. Wenning John Hardy Mina Ryten Eric Topol Ali Torkamani Adriano Chiò David A. Bennett Philip L. De Jager Philip Low Wolfgang Singer William P. Cheshire Zbigniew K. Wszołek Dennis W. Dickson

Highlights•Generation of a foundational genomic resource in multiple system atrophy•GWAS identifies novel risk loci at GAB1, lnc-LRRC49-3, TENM2, and RABGEF1•Functional genomics implicates USP38-DT, KCTD7, lnc-KCTD7-2 within these loci•Gene-burden analysis nominal enrichment rare missense mutations KCTD7SummaryMultiple atrophy (MSA) is an adult-onset, sporadic synucleinopathy characterized by parkinsonism, cerebellar ataxia, dysautonomia. The genetic architecture MSA poorly understood,...

10.1016/j.neuron.2024.04.002 article EN cc-by-nc-nd Neuron 2024-05-02

Alterations in the p38 mitogen-activated protein kinases (MAPKs) play an important role pathogenesis of dementia with Lewy bodies (DLB) and Parkinson's disease (PD). Activation p38α MAPK isoform mislocalization p38γ are associated neuroinflammation synaptic degeneration DLB PD. Therefore, we hypothesized that might be neuronal distribution dysfunction these diseases. To test this hypothesis, treated vitro cellular vivo mouse models DLB/PD SKF-86002, a compound attenuates inflammation by...

10.1126/scitranslmed.abq6089 article EN Science Translational Medicine 2023-05-10

In primates, dorsolateral areas of the prefrontal cortex (PFC) play a major role in visuospatial working memory. To examine functional organization PFC for representing memory, we produced reversible local inactivation, with injection muscimol (5 μg, 1 μl), at various sites ( n = 100) monkeys and observed behavioral consequences an oculomotor delayed-response task that required memory-guided saccades locations throughout both visual fields. At 82 sites, induced deficits to few specific,...

10.1152/jn.2001.86.4.2041 article EN Journal of Neurophysiology 2001-10-01

Tauopathies are neurodegenerative disorders characterized by abnormal intracellular aggregates of tau protein, and include Alzheimer's disease, corticobasal degeneration, frontotemporal dementia, traumatic brain injury. Glutamate metabolism is altered in manifesting higher or lower concentrations glutamate, its transporters receptors. Previously, glutamate chemical exchange saturation transfer (GluCEST) magnetic resonance imaging (MRI) demonstrated that levels reduced regions synapse loss...

10.1002/hipo.22693 article EN Hippocampus 2016-12-20

Abstract Background Although ɑ-synuclein (ɑ-syn) spreading in age-related neurodegenerative diseases such as Parkinson’s disease (PD) and Dementia with Lewy bodies (DLB) has been extensively investigated, the role of aging manifestation remains unclear. Methods We explored inflammation pathogenesis synucleinopathies a mouse model DLB/PD initiated by intrastriatal injection ɑ-syn preformed fibrils (pff). Results found that aged mice showed more extensive accumulation selected brain regions...

10.1186/s13024-022-00564-6 article EN cc-by Molecular Neurodegeneration 2022-09-05

Abstract Synucleinopathies are age-related neurological disorders characterized by the progressive deposition of α-synuclein (α-syn) aggregates and include Parkinson’s disease (PD) dementia with Lewy bodies (DLB). Although cell-to-cell α-syn transmission is thought to play a key role in spread pathology, detailed mechanism still unknown. Neuroinflammation another pathological feature synucleinopathies. Previous studies have identified several immune receptors that mediate neuroinflammation...

10.1038/s12276-021-00562-6 article EN cc-by Experimental & Molecular Medicine 2021-02-01

We examined quantitative changes in biogenic amines relation to effects of population density on growth and behavior the cricket Gryllus bimaculatus, which were reared two different densities, completely isolated solitary 40 crowded insects. In animals, rate increase body weight was slow, also day imaginal moult late, when compared ones. Development thus suppressed group. The color ones darker than that Behavioral tests indicated crickets significantly more aggressive levels amines, their...

10.2108/zsj.12.695 article EN ZOOLOGICAL SCIENCE 1995-12-01
Coming Soon ...